The FDA granted orphan drug status to Kind Pharmaceuticals' investigational oral small molecule AND017 to treat SCD.

Editas Medicine announced proof-of-concept data for a gene-editing approach for sickle cell disease that doesn't need a stem ...

An unfortunate reality is that life costs more when you are disabled. Why is this? Simply put, living with a disability often ...

Note: This column describes the author’s own experiences with various medications, including nonsteroidal anti-inflammatory drugs and oral opioids. Not everyone will have the same response to ...